Monoclonal Antibodies (mAbs) Manufacturing Trends
I would like to learn more about current trends in the monoclonal antibodies (mAbs) manufacturing industry. Specifically, I would like to better understand how COVID-19 and Pharma 4.0 (e.g. automation, AI technology, etc.) are impacting manufacturing of mAbs and what types of changes, if any, are likely to persist in the industry.